Most Effective Stimulation Site in Transcranial Direct Current Stimulation for Gait Recovery After Stoke

NCT03460886 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-09-20

No results posted yet for this study

Summary

The aim of this study is to investigate the most effective stimulation site in transcranial direct current stimulation for gait recovery after stroke. All subjects will go through four conditions of transcranial direct current stimulation with for 30 minutes. Four conditions are 1) bihemispheric stimulation - anodal stimulation on both ipsilesional and contralesional leg area of primary motor cortex and supplementary motor area. 2) ipsilesional stimulation - anodal stimulation on ipsilesional leg area of primary motor cortex and supplementary motor area. 3) contralesional stimulation - anodal stimulation on contralesional leg area of primary motor cortex and supplementary motor area. 4) sham stimulation. Subjects will walk on treadmill for 10 minutes during transcranial direct current stimulation. Motor evoked potential and functional evaluations will be done before and after stimulation to measure the changes.

Conditions

  • Stroke
  • Gait Disorders, Neurologic

Interventions

DEVICE

Ipsilesional stimulation

anodal stimulation on Ipsilesional leg area of primary motor cortex and supplementary motor area for 30 minutes

DEVICE

Contralesional stimulation

anodal stimulation on contralesional leg area of primary motor cortex and supplementary motor area for 30 minutes

OTHER

Walking on treadmill

walking on treadmill for 10 minutes

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2018-05-30
Completion
2018-05-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03460886 on ClinicalTrials.gov